Cargando…

Peanut Allergy: An Overview

Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their t...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ahmed, Nasser, Alsowaidi, Shirina, Vadas, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868887/
https://www.ncbi.nlm.nih.gov/pubmed/20525136
http://dx.doi.org/10.1186/1710-1492-4-4-139
_version_ 1782181085559390208
author Al-Ahmed, Nasser
Alsowaidi, Shirina
Vadas, Peter
author_facet Al-Ahmed, Nasser
Alsowaidi, Shirina
Vadas, Peter
author_sort Al-Ahmed, Nasser
collection PubMed
description Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy range from mild to severe, and risk factors predisposing to severe reactions are discussed. However, even in the absence of risk factors, peanut allergic individuals may still experience life-threatening anaphylactic reactions. Approaches to investigation and treatment, patterns of cross-reactivity and possible causes of rising prevalence are discussed.
format Text
id pubmed-2868887
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28688872010-05-13 Peanut Allergy: An Overview Al-Ahmed, Nasser Alsowaidi, Shirina Vadas, Peter Allergy Asthma Clin Immunol Review Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy range from mild to severe, and risk factors predisposing to severe reactions are discussed. However, even in the absence of risk factors, peanut allergic individuals may still experience life-threatening anaphylactic reactions. Approaches to investigation and treatment, patterns of cross-reactivity and possible causes of rising prevalence are discussed. BioMed Central 2008-12-15 /pmc/articles/PMC2868887/ /pubmed/20525136 http://dx.doi.org/10.1186/1710-1492-4-4-139 Text en Copyright ©2008 The Canadian Society of Allergy, Asthma and Clinical Immunology
spellingShingle Review
Al-Ahmed, Nasser
Alsowaidi, Shirina
Vadas, Peter
Peanut Allergy: An Overview
title Peanut Allergy: An Overview
title_full Peanut Allergy: An Overview
title_fullStr Peanut Allergy: An Overview
title_full_unstemmed Peanut Allergy: An Overview
title_short Peanut Allergy: An Overview
title_sort peanut allergy: an overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868887/
https://www.ncbi.nlm.nih.gov/pubmed/20525136
http://dx.doi.org/10.1186/1710-1492-4-4-139
work_keys_str_mv AT alahmednasser peanutallergyanoverview
AT alsowaidishirina peanutallergyanoverview
AT vadaspeter peanutallergyanoverview